Stockscreener 앱 받기
10.49
5.41%
-0.60
시장 영업 전:
10.47
-0.02
-0.19%
Neogenomics Inc 주식(NEO)의 최신 뉴스
NeoGenomics launches $275M convertible notes offering due 2032 - MSN
NeoGenomics launches $275M convertible notes offering By Investing.com - Investing.com South Africa
NeoGenomics launches $275M convertible notes offering - Investing.com
NeoGenomics Reports Convertible Notes Offering - marketscreener.com
NeoGenomics launches $275M convertible notes offering due 2032 with $41.25M overallotment option - TradingView
NeoGenomics (NASDAQ: NEO) launches $275M 2032 convertible notes and buyback plan - Stock Titan
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes - Business Wire
Lynn Tetrault sells 5,307 NEO shares under 10b5-1 (NASDAQ: NEO) - Stock Titan
NEO News | NEOGENOMICS INC (NASDAQ:NEO) - ChartMill
Neogenomics (NEO) director sells 5,307 shares, retains sizable stake - Stock Titan
[144] NEOGENOMICS INC SEC Filing - Stock Titan
NeoGenomics (NEO) Q1 2025 Earnings Transcript - AOL.com
(NEO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NeoGenomics (NEO) director gains RSU grants and stock options, exercises awards - Stock Titan
Felicia Williams (NASDAQ: NEO) gains shares via RSUs and options - Stock Titan
NeoGenomics (NEO) director boosts holdings through option and RSU awards - Stock Titan
NeoGenomics (NASDAQ: NEO) director exercises RSUs and gains new options - Stock Titan
NeoGenomics (NEO) director adds shares via RSU release and new options - Stock Titan
NeoGenomics (NEO) director exercises 23,077 RSUs and receives new option, RSU grants - Stock Titan
NeoGenomics (NEO) director adds 23,077 shares through RSU vesting - Stock Titan
NeoGenomics (NEO) director reports RSU release and new stock option grants - Stock Titan
NeoGenomics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 6, 2023 to Discuss Your RightsNEO - TMX Newsfile
NeoGenomics Inc (NEO) Stock Up 6.5% and Still Undervalued -- GF Score: 68/100 - GuruFocus
William Blair Maintains NeoGenomics(NEO.US) With Hold Rating - Moomoo
Is NeoGenomics (NEO) Using Its ASCO ctDNA Focus To Redefine Its Precision Oncology Edge? - Yahoo Finance
NeoGenomics Inc. (NEO) Edges Higher as Stock Hovers Near Support in a Consolidative PhaseForce Index - The Legal Advocate
NeoGenomics to Present New Research at ASCO Annual Meeting 2026 - Business Wire
NeoGenomics Inc. (NEO) Edges Higher as Diagnostic Sector Shows Renewed InterestBull Pennant - The Legal Advocate
(NEO) Risk Channels and Responsive Allocation - Stock Traders Daily
NeoGenomics Investor Alert - TMX Newsfile
A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $11 to $25 - Moomoo
Shareholders approve NeoGenomics (NASDAQ: NEO) equity plan amendment and board slate - Stock Titan
NeoGenomics Earnings Call Highlights NGS-Driven Momentum - TipRanks
NeoGenomics stock (US64049M2098): Q1 update keeps focus on cancer testing demand - AD HOC NEWS
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo Finance
NEOGENOMICS (NEO) 13G/A: Greenhouse reports 9,215,903 shares (7.1%) - Stock Titan
NeoGenomics signals $797M-$803M 2026 revenue outlook following PanTracer Liquid MolDX approval - MSN
Oncology diagnostics group NeoGenomics meets investors at May, June conferences - Stock Titan
NeoGenomics to Participate in Upcoming Investor Conferences - The Joplin Globe
(NEO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
This NeoGenomics Insider Reduced Their Stake By 15% - Moomoo
Millennium group reports 2.22M NEO shares (1.7%) — Joint filing (NEO) - Stock Titan
NeoGenomics (NEO) EVP adds shares via RSU vesting while covering taxes - Stock Titan
NeoGenomics (NEO) COO exercises RSUs, withholds shares for taxes and holds 164,032 shares - Stock Titan
TradingKey - TradingKey
Is NeoGenomics’ Higher 2026 Revenue Outlook And Narrower Loss Profile Altering The Investment Case For NEO? - Sahm
NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
NeoGenomics Inc. (NEO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
NeoGenomics to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, July 23, 2015 - ACCESS Newswire
NEO PE Ratio & Valuation, Is NEO Overvalued - Intellectia AI
First Light, Mathew Arens report 10.8% stakes in Neogenomics (NEO) - Stock Titan
NeoGenomics (NEO) Q1 2026 Earnings Transcript - AOL.com
NEO SEC FilingsNeogenomics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NeoGenomics shares jump on earnings and analyst upgrades - MSN
NeoGenomics (NEO) CAO exercises RSUs, surrenders shares for taxes - Stock Titan
NeoGenomics (NEO) EVP updates equity awards, reports tax-withholding share move - Stock Titan
0.56%
0.44%
자본화:
|
볼륨(24시간):